Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Tositumomab

😃Good
Catalog No. T76835Cas No. 192391-48-3
Alias V10XA53, Anti-Human CD20 Recombinant Antibody

Tositumomab is a murine IgG2a lambda monoclonal antibody that selectively binds to the CD20 antigen expressed on the surface of normal and malignant B lymphocytes. Tositumomab is widely utilized in research for B cell-targeted therapies, immunological studies, and the development of radioimmunoconjugates for cancer treatment.

Tositumomab

Tositumomab

😃Good
Purity: 95%
Catalog No. T76835Alias V10XA53, Anti-Human CD20 Recombinant AntibodyCas No. 192391-48-3
Tositumomab is a murine IgG2a lambda monoclonal antibody that selectively binds to the CD20 antigen expressed on the surface of normal and malignant B lymphocytes. Tositumomab is widely utilized in research for B cell-targeted therapies, immunological studies, and the development of radioimmunoconjugates for cancer treatment.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$247-In Stock
5 mg$645-In Stock
10 mg$987-In Stock
25 mg$1,460-In Stock
50 mg$1,970-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:95.1% (SDS-PAGE); 97.5% (SEC-HPLC)
Contact us for more batch information

Product Introduction

Bioactivity
Description
Tositumomab is a murine IgG2a lambda monoclonal antibody that selectively binds to the CD20 antigen expressed on the surface of normal and malignant B lymphocytes. Tositumomab is widely utilized in research for B cell-targeted therapies, immunological studies, and the development of radioimmunoconjugates for cancer treatment.
In vitro
In the mouse xenograft model of human Raji lymphoma cells, Tositumomab (131I-tositumomab) at a dose of 2,035 kBq could inhibit tumor growth and prolong the survival period [1].
In vivo
In the mouse xenograft model of human Raji lymphoma cells, Tositumomab (131I-tositumomab) at a dose of 2,035 kBq could inhibit tumor growth and prolong the survival period [1].
SynonymsV10XA53, Anti-Human CD20 Recombinant Antibody
Reactivity
Human
Application
Functional assay
Antibody Type
Monoclonal
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetCD20
Chemical Properties
Molecular Weight147.25 kDa
Cas No.192391-48-3
ColorTransparent
AppearanceLiquid
Antibody Information
IsotypemIgG2a
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Tositumomab | purchase Tositumomab | Tositumomab cost | order Tositumomab | Tositumomab in vivo | Tositumomab in vitro | Tositumomab molecular weight